Author: healthadmin

Due to the feeling of social isolation, people tend to buy products to soothe their emotions, and the habit often turns into buying flashy products for social evaluation, eventually leading to online shopping addiction. New research published in deviant behavior We will outline this exact psychological sequence. The authors map how private attempts to heal psychological distress transform into public displays of status that reinforce compulsive buying. Online shopping has become deeply integrated into daily life around the world, but its convenience has negative behavioral effects. At its core is online shopping addiction. Online shopping addiction is a condition characterized…

Read More

As data centers consume more energy to keep up with growing digital demands, engineers at the University of California, San Diego have introduced a new chip design that can more efficiently power graphics processing units (GPUs). This innovation focuses on a critical function in electronics: converting high voltages to the lower levels needed by computing hardware. In laboratory tests, the prototype chip was able to perform this type of voltage conversion with high efficiency under conditions similar to modern data centers. The survey results are nature communicationssuggesting the potential for smaller and more energy-efficient systems in advanced computing environments. Rethinking…

Read More

Amneal and BioCorRx have drawn the ire of the FDA’s Office of Prescription Drug Promotion (OPDP), where both companies are accused of violating the agency’s drug marketing regulations. The two drug companies received separate, untitled letters from U.S. regulators in late March detailing the violations, and both were published on the FDA’s website on April 9. The letter to BioCorRx (PDF) centers on the company’s consumer webpage for Lucemyra (lofexidine), a non-opioid prescription drug used by adults to alleviate symptoms of opioid withdrawal. The FDA said the drug’s “webpage is false or misleading (and) misbrands Lucemilla.” This misbranding stems from…

Read More

Researchers tracked more than 13 million days of real-world activity to reveal how step counts can counteract the harms of sitting for too long, while warning that too much sitting still poses lasting risks to the heart. Study: All of Us research program shows daily step count offsets the risk of sedentary behavior. Image credit: Jacek Chabraszewski/Shutterstock.com More than one in three adults spends long periods of time sedentary, which is associated with a higher risk of chronic disease and early death. research in nature communications We found that while not foolproof against certain heart conditions, increasing the number of…

Read More

Recent studies have shown evidence that intense hunger after cannabis use is a neural response that increases the desire to eat, regardless of the body’s actual caloric needs. These findings suggest that cannabis may serve as a medical tool to stimulate appetite in people experiencing weight loss due to chronic illness. This research Proceedings of the National Academy of Sciences. Cannabis is a plant that contains psychoactive compounds, specifically tetrahydrocannabinol (THC). When a person inhales or ingests cannabis, THC interacts with the body’s endocannabinoid system, a complex network of receptors that helps regulate mood, memory, pain, and appetite. Although intense…

Read More

Takeda Pharmaceutical has ended its neurodegenerative disease collaboration with Denali Therapeutics. Merck & Company and Zhifei have eliminated minimum purchase requirements in vaccine distribution agreements. Shionogi & Co. has secured funding from the US government to increase the domestic supply of antibiotics. moreover. 1. Takeda terminates partnership with Denali, returns dementia assets during restructuring Takeda has returned its dementia candidate, coded DNL593, to Denali Therapeutics, effectively ending a collaboration that began in 2018 to jointly develop up to three new drugs for neurodegenerative diseases. According to a filing with Denali Securities, Takeda is in turnaround mode and made this decision…

Read More

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increased risk of lung cancer, mesothelioma, or laryngeal cancer. The survey results are Journal of Thoracic Oncology, Official journal of the International Association for Lung Cancer Research. Access the full study here: https://www.jto.org/article/S1556-0864(26)00163-2/. Evidence suggests a potential link between occupational talc exposure and increased risk of lung cancer and mesothelioma when talc is contaminated with asbestos, a known carcinogen. However, the findings regarding uncontaminated talc were inconclusive. To address this issue, researchers led by Paolo Boffetta…

Read More

Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is currently accepting enrollment for a clinical trial for patients with high-grade neuroendocrine tumors. High-grade neuroendocrine cancer is a complex and progressive disease, but little medical progress has been made, in part because its rarity has constrained research investment. Patients have few options other than conventional chemotherapy. The new trial, led by Dr. Aman Chauhan, leader of Sylvester University’s neuroendocrine tumor program, offers a new approach. Patients are injected directly into their tumors with a combination of immunotherapy drugs and tumor-destroying “oncolytic” viruses. Tumors of any…

Read More

Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesign™, a cloud-native molecular cloning solution that streamlines biopharmaceutical research workflows. Built for biotech and pharmaceutical R&D teams, this platform simplifies complex cloning processes and enables scalable collaborative development in a unified digital environment. Combining essential cloning techniques with enterprise-grade collaboration addresses the limitations of desktop tools and overly complex platforms. Signals BioDesign products provide a complete solution for designing therapeutic constructs across core cloning workflows such as Golden Gate, Gibson assembly, and restriction/ligation, as well as primer design, Sanger sequence analysis, and protein translation in one easy-to-use…

Read More